Product Code: GVR-4-68040-118-6
Collagen Dressing Market Growth & Trends:
The global collagen dressing market size is anticipated to reach USD 570.06 million by 2030, according to a new report by Grand View Research, Inc.. It is anticipated to expand at a CAGR of 4.96% from 2023 to 2030. This can be attributed primarily to the increase in the number of people suffering from various chronic disorders such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. For instance, according to the Agency for Healthcare Research and Quality, every year, more than 2.5 million U.S. residents suffer from pressure ulcers. These are associated with serious infections; therefore, the use of collagen dressing is expected to increase over the forecast duration.
Moreover, a rise in the number of people suffering from leg ulcers may further propel the market growth. For instance, as per NCBI, around 1.5 - 3.0 people in 3,000 have an active leg ulcer at any given point. Similarly, according to the National Health Service, venous leg ulcers are estimated to affect about one in 500 residents in the U.K., thereby boosting the market over the forecast period.
Furthermore, the rising number of surgical procedures is expected to increase the demand for the market. For instance, as per the British Journal of Anaesthesia, approximately 3,102,674 surgical procedures were carried out in the U.K. in the year 2021. Similarly, according to Australian Institute of Health and Welfare, 754,600 patients were admitted for surgery from the public hospital elective surgery waiting list. Thus, the market is expected to grow during the forecast period.
In addition, the number of people suffering from diabetes is increasing year by year. For instance, according to the International Diabetes Federation, the prevalence rate of diabetes among adults in Spain is 14.8%. Moreover, as per the same source, around 537 million people globally have diabetes. The rise in number of diabetes is increasing the risk of diabetic foot ulcers, thereby impelling market growth.
The decline in the COVID-19 population is further anticipated to fuel the growth of the market. Companies in this market are opting for various strategies such as partnerships and distribution agreements to enhance their customer reach during the post COVID-19 period. For instance, in October 2021, Medline launched the Post-Acute Infection Prevention Program. This will be a consultative program that will be focused on post-acute infection prevention. The company will work with the customer to create and provide them with a customized plan regarding best practices for infection control. Moreover, Medline opened 5 new distribution centers in 2021, whereas two more distribution centers are projected for completion in the year 2022. Therefore, such instances are expected to boost the growth of market over the forecast period.
Collagen Dressing Market Report Highlights:
- In terms of form, the gel segment held the largest share of 26.40% in 2022 owing to its compatible nature and better outcome
- Based on source, bovine dominated the market for collagen dressing with a share of 41.76% in 2022 and is anticipated to witness the fastest growth rate over the forecast period
- In terms of type, antimicrobial collagen dressing dominated the market with a market share of 45.89% in 2022, whereas alginate collagen dressing is projected to witness the fastest growth rate over the forecast period
- Based on application, acute wounds segment dominated with the largest market share in 2022. However, chronic wounds segment is expected to grow at fastest CAGR of 5.10%. This can be attributed to rise in number of people suffering from various chronic ailments such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers
- The hospital dominated the end-use segment in 2022, whereas home healthcare is anticipated to witness the fastest growth rate of 5.67% over the forecast period. This can be attributed to rising awareness among people with respect to availability of collagen dressing
- North America is expected to dominate the global market in 2022. However, Asia Pacific is projected to have a fastest growth rate of CAGR 5.55% during the forecast period. This can be credited to presence of large target population base in countries such as China & India
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Form
- 1.1.2. Source
- 1.1.3. Type
- 1.1.4. Application
- 1.1.5. End Use
- 1.1.6. Regional scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Form outlook
- 2.2.2. Source outlook
- 2.2.3. Type outlook
- 2.2.4. Application outlook
- 2.2.5. End use outlook
- 2.2.6. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Collagen Dressing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Global increase in prevalence of chronic disorders
- 3.4.1.2. Increasing number of surgical procedures
- 3.4.1.3. Increasing number of traumatic accidents and burns incidence
- 3.4.1.4. Increasing global geriatric population
- 3.4.2. Market restraint analysis
- 3.4.2.1. Availability of suitable alternative for collagen dressing
- 3.4.2.2. Delayed diagnosis and treatment in emerging nations
- 3.5. Collagen Dressing Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.2.4. Major Deals & Strategic Alliances Analysis
- 3.5.2.5. Market Entry Strategies
Chapter 4. Collagen Dressing Market: Form Estimates & Trend Analysis
- 4.1. Form Market Share, 2022 & 2030
- 4.2. Segment Dashboard
- 4.3. Collagen Dressing Market by Form Outlook
- 4.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
- 4.4.1. Gel
- 4.4.1.1. Gel market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.2. Pads
- 4.4.2.1. Pads market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.3. Powder
- 4.4.3.1. Powder market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.4. Sheet
- 4.4.4.1. Sheet market estimates and forecast 2018 to 2030 (USD Million)
- 4.4.5. Others
- 4.4.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Collagen Dressing Market: Source Estimates & Trend Analysis
- 5.1. Collagen Dressing Market Share, 2022 & 2030
- 5.2. Segment Dashboard
- 5.3. Collagen Dressing Market by Source Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Bovine
- 5.4.1.1. Bovine market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.2. Equine
- 5.4.2.1. Equine market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.3. Others
- 5.4.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Collagen Dressing Market: Type Estimates & Trend Analysis
- 6.1. Type Market Share, 2022 & 2030
- 6.2. Segment Dashboard
- 6.3. Collagen Dressing Market by Type Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Antimicrobial Collagen Dressing
- 6.4.1.1. Antimicrobial collagen dressing market estimates and forecast 2018 to 2030 (USD Million)
- 6.4.2. Hydrogel Collagen Dressings
- 6.4.2.1. Hydrogel collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
- 6.4.3. Alginate Collagen Dressings
- 6.4.3.1. Alginate collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Collagen Dressing Market: Application Estimates & Trend Analysis
- 7.1. Application Market Share, 2022 & 2030
- 7.2. Segment Dashboard
- 7.3. Collagen Dressing Market by Application Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.4.1. Chronic Wounds
- 7.4.1.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 7.4.1.1.1. Diabetic foot ulcer
- 7.4.1.1.1.1. Diabetic foot ulcer market estimates and forecast 2018 to 2030 (USD Million)
- 7.4.1.1.2. Venous leg ulcer
- 7.4.1.1.2.1. Venous leg ulcer market estimates and forecast 2018 to 2030 (USD Million)
- 7.4.1.1.3. Pressure ulcer
- 7.4.1.1.3.1. Pressure ulcer market estimates and forecast 2018 to 2030 (USD Million)
- 7.4.1.1.4. Other chronic wounds
- 7.4.1.1.4.1. Other chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 7.4.2. Acute Wounds
- 7.4.2.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
- 7.4.2.1.1. Surgical and traumatic wounds
- 7.4.2.1.1.1. Surical and traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 7.4.2.1.2. Burns
- 7.4.2.1.2.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Collagen Dressing Market: End Use Estimates & Trend Analysis
- 8.1. End Use Market Share, 2022 & 2030
- 8.2. Segment Dashboard
- 8.3. Collagen Dressing Market by End Use Outlook
- 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.4.1. Hospitals
- 8.4.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 8.4.2. Specialty Clinics
- 8.4.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
- 8.4.3. Home Healthcare
- 8.4.3.1. Home Healthcare market estimates and forecast 2018 to 2030 (USD Million)
- 8.4.4. Others
- 8.4.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Collagen Dressing Market: Regional Estimates & Trend Analysis
- 9.1. Regional market share analysis, 2022 & 2030
- 9.2. Regional Market Dashboard
- 9.3. Regional and Country Market Share and Leading Players, 2022
- 9.4. Market Estimate & Forecasts and Trend Analysis, 2018 to 2030:
- 9.5. North America
- 9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.5.2. U.S.
- 9.5.2.1. Key country dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. Regulatory framework
- 9.5.2.4. Reimbursement scenario
- 9.5.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 9.5.3. Canada
- 9.5.3.1. Key country dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Regulatory framework
- 9.5.3.4. Reimbursement scenario
- 9.5.3.5. Canada market estimates and forecasts, 2018 - 2030
- 9.6. Europe
- 9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.6.2. UK
- 9.6.2.1. Key country dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Regulatory framework
- 9.6.2.4. Reimbursement scenario
- 9.6.2.5. UK market estimates and forecasts, 2018 - 2030
- 9.6.3. Germany
- 9.6.3.1. Key country dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. Regulatory framework
- 9.6.3.4. Reimbursement scenario
- 9.6.3.5. Germany market estimates and forecasts, 2018 - 2030
- 9.6.4. France
- 9.6.4.1. Key country dynamics
- 9.6.4.2. Competitive Scenario
- 9.6.4.3. Regulatory framework
- 9.6.4.4. Reimbursement scenario
- 9.6.4.5. France market estimates and forecasts, 2018 - 2030
- 9.6.5. Italy
- 9.6.5.1. Key country dynamics
- 9.6.5.2. Competitive Scenario
- 9.6.5.3. Regulatory framework
- 9.6.5.4. Reimbursement scenario
- 9.6.5.5. Italy market estimates and forecasts, 2018 - 2030
- 9.6.6. Spain
- 9.6.6.1. Key country dynamics
- 9.6.6.2. Competitive Scenario
- 9.6.6.3. Regulatory framework
- 9.6.6.4. Reimbursement scenario
- 9.6.6.5. Spain market estimates and forecasts, 2018 - 2030
- 9.7. Asia Pacific
- 9.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.7.2. Japan
- 9.7.2.1. Key country dynamics
- 9.7.2.2. Competitive Scenario
- 9.7.2.3. Regulatory framework
- 9.7.2.4. Reimbursement scenario
- 9.7.2.5. Japan market estimates and forecasts, 2018 - 2030
- 9.7.3. China
- 9.7.3.1. Key country dynamics
- 9.7.3.2. Competitive Scenario
- 9.7.3.3. Regulatory framework
- 9.7.3.4. Reimbursement scenario
- 9.7.3.5. China market estimates and forecasts, 2018 - 2030
- 9.7.4. India
- 9.7.4.1. Key country dynamics
- 9.7.4.2. Competitive Scenario
- 9.7.4.3. Regulatory framework
- 9.7.4.4. Reimbursement scenario
- 5.7.4.5. India market estimates and forecasts, 2018 - 2030
- 9.7.5. Australia
- 9.7.5.1. Key country dynamics
- 9.7.5.2. Competitive Scenario
- 9.7.5.3. Regulatory framework
- 9.7.5.4. Reimbursement scenario
- 9.7.5.5. Australia market estimates and forecasts, 2018 - 2030
- 9.7.6. South Korea
- 9.7.6.1. Key country dynamics
- 9.7.6.2. Competitive Scenario
- 9.7.6.3. Regulatory framework
- 9.7.6.4. Reimbursement scenario
- 9.7.6.5. South Korea market estimates and forecasts, 2018 - 2030
- 9.8. Latin America
- 9.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.8.2. Brazil
- 9.8.2.1. Key country dynamics
- 9.8.2.2. Competitive Scenario
- 9.8.2.3. Regulatory framework
- 9.8.2.4. Reimbursement scenario
- 9.8.2.5. Brazil market estimates and forecasts, 2018 - 2030
- 9.8.3. Mexico
- 9.8.3.1. Key country dynamics
- 9.8.3.2. Competitive Scenario
- 9.8.3.3. Regulatory framework
- 9.8.3.4. Reimbursement scenario
- 9.8.3.5. Mexico market estimates and forecasts, 2018 - 2030
- 9.8.4. Colombia
- 9.8.4.1. Key country dynamics
- 9.8.4.2. Competitive Scenario
- 9.8.4.3. Regulatory framework
- 9.8.4.4. Reimbursement scenario
- 9.8.4.5. Colombia market estimates and forecasts, 2018 - 2030
- 9.8.5. Argentina
- 9.8.5.1. Key country dynamics
- 9.8.5.2. Competitive Scenario
- 9.8.5.3. Regulatory framework
- 9.8.5.4. Reimbursement scenario
- 9.8.5.5. Argentina market estimates and forecasts, 2018 - 2030
- 9.9. Middle East and Africa
- 9.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.9.2. South Africa
- 9.9.2.1. Key country dynamics
- 9.9.2.2. Competitive Scenario
- 9.9.2.3. Regulatory framework
- 9.9.2.4. Reimbursement scenario
- 9.9.2.5. South Africa market estimates and forecasts, 2018 - 2030
- 9.9.3. Saudi Arabia
- 9.9.3.1. Key country dynamics
- 9.9.3.2. Competitive Scenario
- 9.9.3.3. Regulatory framework
- 9.9.3.4. Reimbursement scenario
- 9.9.3.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 9.9.4. UAE
- 9.9.4.1. Key country dynamics
- 9.9.4.2. Competitive Scenario
- 9.9.4.3. Regulatory framework
- 9.9.4.4. Reimbursement scenario
- m 5.9.4.5. UAE market estimates and forecasts, 2018 - 2030
Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis, By Key Market Participants
- 10.2. Company/Competition Categorization
- 10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
- 10.3.3. Key company market share analysis, 2022
- 10.3.4. Smith & Nephew
- 10.3.4.1. Company overview
- 10.3.4.2. Financial performance
- 10.3.4.3. Product benchmarking
- 10.3.4.4. Strategic initiatives
- 10.3.5. Paul Hartmann
- 10.3.5.1. Company overview
- 10.3.5.2. Financial performance
- 10.3.5.3. Product benchmarking
- 6.3.5.4. Strategic initiatives
- 10.3.6. Sanara MedTech Inc
- 10.3.6.1. Company overview
- 10.3.6.2. Financial performance
- 10.3.6.3. Product benchmarking
- 10.3.6.4. Strategic initiatives
- 10.3.7. 3M
- 10.3.7.1. Company overview
- 10.3.7.2. Financial performance
- 10.3.7.3. Product benchmarking
- 10.3.7.4. Strategic initiatives
- 10.3.8. Lohmann & Rauscher
- 10.3.8.1. Company overview
- 6.3.8.2. Financial performance
- 6.3.8.3. Product benchmarking
- 6.3.8.4. Strategic initiatives
- 10.3.9. Derma Rite Industries, LLC
- 10.3.9.1. Company overview
- 10.3.9.2. Financial performance
- 10.3.9.3. Product benchmarking
- 10.3.9.4. Strategic initiatives
- 10.3.10 Integra LifeSciences
- 10.3.10.1 Company overview
- 10.3.10.2 Financial performance
- 10.3.10.3 Product benchmarking
- 10.3.10.4 Strategic initiatives
- 10.3.11 Coloplast Corp.
- 10.3.11.1 Company overview
- 10.3.11.2 Financial performance
- 10.3.11.3 Product benchmarking
- 10.3.11.4 Strategic initiatives
- 10.3.12 McKesson Corporation
- 10.3.12.1 Company overview
- 10.3.12.2 Financial performance
- 10.3.12.3 Product benchmarking
- 10.3.12.4 Strategic initiatives
- 10.3.13 Medline Industries
- 10.3.13.1 Company overview
- 10.3.13.2 Financial performance
- 10.3.13.3 Product benchmarking
- 10.3.13.4 Strategic initiatives
- 10.3.14 Johnson & Johnson (Ethicon)
- 10.3.14.1 Company overview
- 10.3.14.2 Financial performance
- 10.3.14.3 Product benchmarking
- 10.3.14.4 Strategic initiatives